Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-020-18388-7
Affiliations:
7
Authors:
18
Go to article
Institutions Authors Share
University Children's Hospital of Zurich, Switzerland
9.500000
 0.53
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands
2.500000
 0.14
NIH NCI Center for Cancer Research (CCR), United States of America (USA)
2.000000
 0.11
University Hospital Zurich (UHZ), Switzerland
1.000000
 0.06
Cancer, Heterogeneity, Instability and Plasticity (CHIP), France
1.000000
 0.06
Ligue Contre Le Cancer, France
1.000000
 0.06
Tata Memorial Hospital (TMH), TMC, India
1.000000
 0.06